As the shift in cannabis trends continues, Organigram Holdings (NASDAQ:OGI,TSXV:OGI) credits its US senior listing as a new source of funding from mature investors.
During the Lift & Co. (TSXV:LIFT,OTCQB:LFCOF) Cannabis Expo in Toronto, Greg Engel, CEO of Organigram, talked with the Investing News Network (INN) about the impact the firm has seen since obtaining a NASDAQ listing.
In May, Organigram became the third Canadian marijuana producer to list on the NASDAQ.
Engel told INN one of the determining factors for the company in securing this listing was newfound interest in investment for the company in the US.
“We’ve seen that with larger, more traditional funds entering the space, so by going to the NASDAQ it gives us access to those funds, it gives (investors the) ability to now invest in us as a company.”
The executive said producers in Canada have faced a sobering period of time where investment metrics have shifted from funded capacity to actual results in the Canadian legal space.
“I think where the separation is happening is between the larger, consistent providers like Organigram and some of the smaller companies, and some of those companies are really struggling to access capital now,” he said.
Engel confirmed the company is examining opportunities to access the US market by way of the hemp-derived cannabidiol product space, which has garnered attention from fellow Canadian producers.
For more on what Engel had to say, watch the interview above. You can also click here to see our full Lift & Co. Cannabis Expo playlist on YouTube.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.
Both locations expand access to the state’s widest-ranging inventory of medical cannabis products for Central Florida patients
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of two brand-new Central Florida dispensaries. The new Clearwater and Tampa locations mark the Company’s 81 st and 82 nd nationwide, respectively, widening patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Philip Young, CEO and Director of Lobe, stated, “We are honored to welcome Bart to our Advisory Board. His first-hand experience on and off the field are tremendously valuable as we continue our research involving mild traumatic brain injuries and PTSD. These issues are prevalent in contact sports and we believe that athletes will play a prominent role in the continued acceptance of psychedelic medicines as legitimate treatment. We look forward to working with Bart as we seek to forge long-term strategic relationships.”
HempFusion Wellness Submits Novel Foods Dossier to the United Kingdom’s Regulatory Food Safety Agency
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has submitted its dossier to the United Kingdom’s Regulatory Food Safety Agency (the “FSA”).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210303005322/en/